Dr. Avnish Bhatia, MD

Dr. Bhatia practices at Thomas Jefferson University Hospital in Philadelphia, Pennsylvania, part of Thomas Jefferson University.

Dr. Bhatia's NPI, 1528273760, was assigned on May 11, 2007. Dr. Bhatia graduated from Drexel University College Of Medicine in 2002. Dr. Bhatia holds Pennsylvania license MD433959.

Dr. Bhatia's primary practice is Thomas Jefferson University Hospital, at 111 South 11th Street, Philadelphia, PA 19107 in Philadelphia County. The practice phone is (215) 955-6000.

Dr. Bhatia's primary practice is Thomas Jefferson University Hospital in Philadelphia, Pennsylvania, part of Thomas Jefferson University. Dr. Bhatia is also affiliated with Jefferson Torresdale Hospital. The medical group on file is Jefferson University Physicians. Dmand AI also links Dr. Bhatia to 2 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bhatia practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Bhatia's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Bhatia is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Bhatia's licenses on file in 4 states: Pennsylvania, Delaware, New Jersey and New York.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), fluid and electrolyte imbalances, lung cancer and multiple myeloma among the conditions Dr. Bhatia treats.

CMS data shows 388 Medicare services from Dr. Bhatia across 8 procedure codes in 2024, for 171 Medicare patients. Medicare paid $41,942 for them.

CMS counts 171 Medicare patients who saw Dr. Bhatia in 2024. The largest group is 65 to 74, with 84 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 2.30, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bhatia's median patient age at 70, with 46% women.

In 2024, Dr. Bhatia wrote 442 Medicare Part D claims for 89 patients. 83% of them were for generic drugs. CMS names the drug for 267 of them, across 14 drugs with 11 or more claims each, at $18,951 in total drug cost. In 2023, CMS named 222 claims across 11 drugs.

Dr. Bhatia accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bhatia as offering telehealth.

Dmand AI links Dr. Bhatia to 6 clinical trials, 2 of them phase 1/2 studies. Conditions studied include Carcinoma, Renal Cell, Inflammatory Breast Neoplasms and Liver Neoplasms. Sidney Kimmel Cancer Center at Thomas Jefferson University sponsors the most, 5.

CMS Open Payments shows 28 general payments to Dr. Bhatia from 13 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 96% of the total. Astellas Pharma US Inc paid the most, $110.

Dmand AI lists 2 awards for Dr. Bhatia, most recently NCQA PCSP in 2017.

Dr. Bhatia graduated from Drexel University College Of Medicine in 2002.

Dr. Bhatia is in network with 21 carriers, including Aetna, Highmark and United Healthcare. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.